Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Christian K Kollmannsberger"'
Autor:
Howard Gurney, Thomas Powles, Laurence Albiges, Camillo Porta, Toni K Choueiri, Marc-Oliver Grimm, Elizabeth R Plimack, Brian I Rini, Saby George, Robert J Motzer, Frede Donskov, Philippe Barthélémy, Christian K Kollmannsberger, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir, Mauricio Burotto, Daniel Castellano
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Purpose To report updated analyses of the phase III CheckMate 214 trial with extended minimum follow-up assessing long-term outcomes with first-line nivolumab plus ipilimumab (NIVO+IPI) versus (vs) sunitinib (SUN) in patients with advanced renal cell
Externí odkaz:
https://doaj.org/article/f54750c49b2c4a85a39b1e7b5272d449
Autor:
Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Viktor Grünwald, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The extent to which response and survival benefits with immunotherapy-based regimens persist informs optimal first-line treatment options. We provide long-term follow-up in patients with advanced renal cell carcinoma (aRCC) receiving first
Externí odkaz:
https://doaj.org/article/633526ea5f4546a1a54c5f374b846edf
Autor:
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, Lori Wood, Georg A. Bjarnason, Bimal Bhindi, Daniel Yick Chin Heng, Vincent Castonguay, Frederic Pouliot, Christian K. Kollmannsberger, Dominick Bosse, Naveen S. Basappa, Antonio Finelli, Nazanin Fallah-rad, Rodney H. Breau, Aly-Khan A. Lalani, Simon Tanguay, Jeffrey Graham, Ramy R. Saleh
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4704-4712 (2024)
Immunotherapy-based systemic treatment (ST) is the standard of care for most patients diagnosed with metastatic renal cell carcinoma (mRCC). Cytoreductive nephrectomy (CN) has historically shown benefit for select patients with mRCC, but its role and
Externí odkaz:
https://doaj.org/article/a3dcd2b35cca4280bfb0bb15774ac56f
Autor:
Kim N. Chi, Steven M. Yip, Glenn Bauman, Stephan Probst, Urban Emmenegger, Christian K. Kollmannsberger, Patrick Martineau, Tamim Niazi, Frédéric Pouliot, Ricardo Rendon, Sebastien J. Hotte, David T. Laidley, Fred Saad
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1400-1415 (2024)
Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer and a therapeutic target. Lutetium-177 (177Lu)-PSMA-617 is the first radioligand therapy to be approved in Canada for use in patients with metastatic castration-resistan
Externí odkaz:
https://doaj.org/article/64b195e581c7483cb8fda268b1214380
Autor:
Esmail M. Al-Ezzi, Amer Zahralliyali, Aaron R. Hansen, Robert J. Hamilton, Michael Crump, John Kuruvilla, Lori Wood, Lucia Nappi, Christian K. Kollmannsberger, Scott A. North, Eric Winquist, Denis Soulières, Sebastien J. Hotte, Di Maria Jiang
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6166-6176 (2023)
Background: Although metastatic germ cell tumor (GCT) is highly curable with initial cisplatin-based chemotherapy (CT), 20–30% of patients relapse. Salvage CT options include conventional (CDCT) and high dose chemotherapy (HDCT), however definitive
Externí odkaz:
https://doaj.org/article/cdf6575c6dd6426a9ccb2edad31d8e08
Autor:
Jean-Michel Lavoie, Priya Baichoo, Elizabeth Chavez, Lucia Nappi, Daniel Khalaf, Christian K. Kollmannsberger, Kim N. Chi, Andrew Weng, Christian Steidl, Bernhard J. Eigl, Michael Nissen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Immune checkpoint inhibitors (ICI) are used in the treatment of urothelial and renal cell cancers. While some patients may have exceptional responses, better predictive biomarkers are needed. We profiled the circulating immune compartment of patients
Externí odkaz:
https://doaj.org/article/5516a4945ece4cb4acf0697755e5726b
Autor:
Bimal Bhindi, Simon Tanguay, Frédéric Pouliot, Christina Canil, Sebastien J. Hotte, Alan I. So, Alice Dragomir, Daniel Heng, Rodney H. Breau, Nicholas Power, Jean-Baptiste Lattouf, Sara Nazha, Aaron R. Hansen, Ricardo A. Rendon, Antonio Finelli, Adrian Fairey, Lori Wood, Christian K. Kollmannsberger, Georg A. Bjarnason, Naveen S. Basappa, Anil Kapoor
Publikováno v:
European Urology Focus. 8:1703-1710
Background Treatment options for metastatic renal cell carcinoma (mRCC) include cytoreductive nephrectomy (CN) and systemic therapy (ST). Results from the CARMENA and SURTIME trials suggest that CN before ST may not be the optimal treatment strategy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0655b2a531f3a154557cd988fd8b415
https://doi.org/10.1016/j.euf.2021.10.004
https://doi.org/10.1016/j.euf.2021.10.004
Autor:
Jack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, Ladan Fazli, Neetu Saxena, Guliz Ozgun, Maryam Soleimani, Kim Chi, Craig Nichols, Andrea Necchi, Alexander W Wyatt, Christian K Kollmannsberger, Lucia Nappi
Publikováno v:
The Oncologist. 27:e912-e915
Background Primary mediastinal nonseminoma germ cell tumors (PMNSGCT) are a subgroup of nonseminoma germ cell tumors (GCT) with poor prognosis. In this study, PMNSGCT-specific genomic landscape was analyzed and correlated with clinical outcomes. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ebd859f04fcb1ba44be6b12031a662
https://doi.org/10.1093/oncolo/oyac197
https://doi.org/10.1093/oncolo/oyac197
Autor:
Jiang, Esmail M. Al-Ezzi, Amer Zahralliyali, Aaron R. Hansen, Robert J. Hamilton, Michael Crump, John Kuruvilla, Lori Wood, Lucia Nappi, Christian K. Kollmannsberger, Scott A. North, Eric Winquist, Denis Soulières, Sebastien J. Hotte, Di Maria
Publikováno v:
Current Oncology; Volume 30; Issue 7; Pages: 6166-6176
Background: Although metastatic germ cell tumor (GCT) is highly curable with initial cisplatin-based chemotherapy (CT), 20–30% of patients relapse. Salvage CT options include conventional (CDCT) and high dose chemotherapy (HDCT), however definitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::e8b0ceef8457ec32071ed6f5d12ab154
Autor:
Susan Halabi, Daniel J. George, Andrew Protheroe, Christopher W. Ryan, Lisa M. Pickering, Igor Puzanov, Theodore F. Logan, Christian K. Kollmannsberger, John D. Hainsworth, Robert E. Hawkins, Joel Picus, Ulka N. Vaishampayan, Jorge A. Garcia, Robert J. Jones, Walter M. Stadler, Tim Eisen, Qian Yang, Andrea Carmack, Andrew B. Nixon, Andrew J. Armstrong
Supplementary Figure 3. Kaplan-Meier OS curves by dichotomized angiokines: VEGF-D, VEGF, VEGF-R1, PDGF-AA, TGF-b1, VEGF-R3, HER-3, BMP-9, CD-73, VEGF-R2, TGF-b2, SDF-1, PDGF-BB, and TGFb-R3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1092d144e84b1ce021a4efc182ba5459
https://doi.org/10.1158/1078-0432.22478720
https://doi.org/10.1158/1078-0432.22478720
